Group medical visits in the follow-up of women with a BRCA mutation: design of a randomized controlled trial

BACKGROUND: BRCA mutation carriers have a 40-80% life-time risk of developing breast cancer. They may opt for yearly breast cancer surveillance or for prophylactic mastectomy. Both options show increased survival rates. It is a complex choice to be made between these two options. As a result most wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Visser, Annemiek, Prins, Judith B, Hoogerbrugge, Nicoline, van Laarhoven, Hanneke WM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174867/
https://www.ncbi.nlm.nih.gov/pubmed/21864353
http://dx.doi.org/10.1186/1472-6874-11-39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174867/
https://www.ncbi.nlm.nih.gov/pubmed/21864353
http://dx.doi.org/10.1186/1472-6874-11-39

Ejemplares similares